Home Tags MRNA

Tag: MRNA

CureVac is an Underappreciated Opportunity, Says UBS

Investors may want to keep an eye on CureVac (CVAC). After pulling back from about $12.50 to $10.50, CVAC could see higher highs.  In fact,...

The Top 3 Vaccine Trades that Should be in All Portfolios

Moderna (MRNA) has been incredibly explosive for us. The first time we highlighted opportunity, the stock traded at $72 on Oct. 20.  At the moment,...

This is Why Moderna Could Run to $200, Near-Term

Vaccine news has created big opportunity. Look at BioNTech for example.  The stock exploded from $88.50 to $124.24 after it and Pifzer said its vaccine had...

Moderna Inc. Could Have Vaccine by December 2020

Keep an eye on Moderna Inc. (MRNA). The COVID-19 vaccine stock is regaining some lost ground.  All after CEO Stephane Bancel said the U.S. government...

Popular Post